EUVIMEDEUVIMED entdecken
Vergleichsstudie

Efficacy and Morbidity of Heparin Infusion in Salvaging Autologous Breast Reconstruction Free Flaps

Scott K Odorico iD, Muhammad Sabry Mazroua, Leda Wang, Andrew Awadallah, Serena Day, Christin Harless, Jorys Martinez-Jorge, Aparna Vijayasekaran

Microsurgery · 2025-05 · 45 (4)

DOI: 10.1002/micr.70065 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microsurgery, online erschienen am 08.05.2025. Verfasst von Scott K Odorico und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Heparin, Mammaplasty, Free Tissue Flaps, Anticoagulants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Abdominal‐based free flaps are the mainstay in autologous breast reconstruction. Their safety and consistency in outcomes are well‐documented. When flap compromise occurs, operative salvage is the gold standard. However, when—and if—to place these patients on heparin infusions is unclear. The goal of this study was to investigate abdominal‐based free flap compromise and compare outcomes with and without heparin infusion. Materials and Methods This was a single‐institution, multiple‐surgeon, retrospective chart review of patients undergoing autologous, abdominal‐based free flap breast reconstruction who experienced anastomotic compromise within a 6‐year period. Treatment and outcomes data collected include flap salvage, hematoma, seroma, surgical site infection (SSI), transfusion requirement, and length of hospital stay.

Results

Fifty‐one flaps had evidence of compromise. A total of 31 (60.8%) patients were placed on heparin infusions after experiencing anastomotic compromise, compared to 20 who did not receive heparin infusion. Thirty‐five patients (68.6%) underwent deep inferior epigastric perforator flaps. Twenty‐six patients (51%) experienced venous congestion, 22 patients (43.1%) experienced arterial compromise, and three (5.9%) experienced both. Twenty‐eight patients (54.9%) received tissue plasminogen activator; in the heparin infusion group, 21 patients (67.7%) received tissue plasminogen activator. The total salvage rate of compromised flaps was 94.1% (48/51). There was no significant difference between heparin infusion and standard cares in length of hospital stay, length of drains in‐place, successful salvage (93.5% vs. 95%), hematoma (19.4% vs. 15%), fat necrosis, SSI, hospital readmission (19.4% vs. 15%), and return rates to the operating room (48.4% vs. 50%). However, there was a significantly higher transfusion rate in patients receiving heparin infusion (38.7% vs. 10%). Of the 25 flaps with evidence of thrombosis, 72% were placed on heparin infusions while 28% were not; there was no significant difference in salvage rate in this sub‐group.

Conclusions

This review of autologous breast reconstruction free flap compromise provides evidence of similar safety profiles, with similar salvage rates, when comparing salvage with and without heparin infusion; there is a higher transfusion requirement when treating with heparin infusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinMammaplastyFree Tissue FlapsAnticoagulantsPostoperative ComplicationsHumansFemaleRetrospective StudiesMiddle AgedAdultTreatment OutcomeTransplantation, AutologousInfusions, IntravenousSalvage TherapyLength of StayAged

Stichwörter der Autor:innen

autologous breast reconstructioncomplicationheparinsalvagethrombus

Substanzen

HeparinAnticoagulants

Autor:innen und Institutionen

  • Division of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Scott K Odorico

Zitieren

APA

Odorico, S. K., Mazroua, M. S., Wang, L., Awadallah, A., Day, S., Harless, C., Martinez-Jorge, J., & Vijayasekaran, A. (2025). Efficacy and Morbidity of Heparin Infusion in Salvaging Autologous Breast Reconstruction Free Flaps. Microsurgery, 45(4). https://doi.org/10.1002/micr.70065

Vancouver

Odorico SK, Mazroua MS, Wang L, Awadallah A, Day S, Harless C, et al. Efficacy and Morbidity of Heparin Infusion in Salvaging Autologous Breast Reconstruction Free Flaps. Microsurgery. 2025;45(4). doi:10.1002/micr.70065

BibTeX
@article{Odorico2025,
  author = {Odorico, Scott K and Mazroua, Muhammad Sabry and Wang, Leda and Awadallah, Andrew and Day, Serena and Harless, Christin and Martinez-Jorge, Jorys and Vijayasekaran, Aparna},
  title = {Efficacy and Morbidity of Heparin Infusion in Salvaging Autologous Breast Reconstruction Free Flaps},
  journal = {Microsurgery},
  year = {2025},
  volume = {45},
  number = {4},
  doi = {10.1002/micr.70065}
}
Kostenlos starten →